A new option for adults who have experienced stroke will now be available to further reduce future risk.
News|Articles|April 16, 2008
Rx to OTC drug switches making a comeback
Rx to OTC drug switches are forecast to increase in the coming years, according to a new study by Kalorama.
Advertisement
There are 14 prescription drugs that exceed $20 billion in sales in 2006 that may have the potential to reach the over-the-counter market in four years. Prescription-to-OTC switches were frequent in 2006 and 2007 and, according to a new report by
Advertisement
Related to this article
Findings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.
Gilead’s current lenacapavir patent is what makes Dr Reddy’s Laboratories’ formulation tentative.
The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
The Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.
Through the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.
The medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.
In part 3, Rebold explores improving the ART formulary protocol through introducing pharmacist-led transition-of-care services.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Adds NAION Eye Risk Warning to All GLP-1 Labels
2
The Pharmacy Model Creating New Billing Pathways, Improved Recognition
3
Doxycycline Use Associated with Higher Risk of Pregnancy Loss
4
New Report Finds Pharmacies Key in Long-Term GLP-1 Success
5